Serologicals, a provider of biological products and services. Is acquiring a drug discovery services firm based in the United Kingdom.

Financial terms of the deal for Cytomyx Ltd. Were not disclosed.

Cytomyx is provider of drug discovery services and ion channel cell lines, which have been linked to a number of pathologies such as cardiac disease, hypertension and cystic fibrosis.